MedTrace Logo

Estimation of Off-Label Use of XGEVA® (Denosumab) Using Population-Based Databases in Denmark

NCT02066805 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 142

Last updated 2015-05-29

No results posted yet for this study

Summary

This study aims to evaluate off-label XGEVA use in Denmark using data linked from registries and other sources in Northern Jutland Region and Copenhagen. This will allow for accurate assessment of prescriptions and diagnoses, especially those related to cancer patients during the first year post the initial market availability of XGEVA.

Conditions

  • XGEVA Off-label Use

Interventions

DRUG

Database assessment of off-label XGEVA use

No intervention is planned during this study as it involves analyses of patient electronic records from Northern Jutland Region and Copenhagen

Sponsors & Collaborators

  • University of Aarhus

    collaborator OTHER

  • Amgen

    lead INDUSTRY

Principal Investigators

  • MD · Amgen

Eligibility

Sex
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2015-02-28
Completion
2015-02-28

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02066805 on ClinicalTrials.gov